The Combination of SELINEXOR (KPT-330), a Selective Inhibitor of Nuclear Export (SINE), and the FLT3 Inhibitor QUIZARTINIB Shows Anti-Tumor Activity in Acute Myeloid Leukemia (AML) In-Vitro and In-Vivo
The Combination of SELINEXOR (KPT-330), a Selective Inhibitor of Nuclear Export (SINE), and the FLT3 Inhibitor QUIZARTINIB Shows Anti-Tumor Activity in Acute Myeloid Leukemia (AML) In-Vitro and In-Vivo